Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model.

about

Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines.Trial watch: DNA-based vaccines for oncological indications Recent advances in the management of anal cancer

P2860

Q54249887-2EFA9C8F-8547-427B-BE81-A9D4B02D82C6 Q56893452-9EED96A6-B662-49A2-BC53-C7B280A37A16 Q57821008-34DCD1B5-2FFF-4B1A-B8CF-81DEE432ABCA

P2860

Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model.

Item

http://www.wikidata.org/entity/Q38700706

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Characterization of HPV18 E6-s ...... V18 E6-expressing tumor model.

@en

type

Item

label

Characterization of HPV18 E6-s ...... V18 E6-expressing tumor model.

@en

prefLabel

Characterization of HPV18 E6-s ...... V18 E6-expressing tumor model.

@en

P1476

Characterization of HPV18 E6-s ...... V18 E6-expressing tumor model.

@en

P2093

Andrew Yang

http://www.w3.org/2001/XMLSchema#string

Chien-Fu Hung

http://www.w3.org/2001/XMLSchema#string

Emily Farmer

http://www.w3.org/2001/XMLSchema#string

Jin Qiu

http://www.w3.org/2001/XMLSchema#string

Shiwen Peng

http://www.w3.org/2001/XMLSchema#string

T-C Wu

http://www.w3.org/2001/XMLSchema#string

Ying Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia

Perspectives for therapeutic HPV vaccine development

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells.

Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer.

Prospective study of human papillomavirus and risk of cervical adenocarcinoma

Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase.

Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival.

P304

3850-3858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2017.05.081

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28599791

http://www.w3.org/2001/XMLSchema#string

P932

5524135

http://www.w3.org/2001/XMLSchema#string

Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model.

about

P2860

P2860

Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932